Plasmodium vivax malaria admissions and risk of mortality in a tertiary-care children's hospital in North India

Paediatrics and International Child Health

Volumn 32, Issue 3, 2012, Pages 152-157

  Sharma, Rajni ^a   Gohain, Suraj ^a   Chandra, Jagdish ^a   Kumar, Virendra ^a   Chopra, Abhishek ^a   Chatterjee, Sayan ^a   Aneja, Satinder ^a   Dutta, Ashok Kumar ^a  

^a KALAWATI SARAN CHILDREN'S HOSPITAL   (India)

Author keywords

Acute respiratory distress syndrome; Severe malaria; Thrombocytopenia

Indexed keywords

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT RESPIRATORY DISTRESS SYNDROME; ANEMIA; BRAIN MALARIA; CHILD; CHILDHOOD MORTALITY; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INDIA; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORBIDITY; MULTIPLE ORGAN FAILURE; PARASITE IDENTIFICATION; PATIENT ASSESSMENT; PLASMODIUM VIVAX MALARIA; PRESCHOOL CHILD; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SEASONAL VARIATION; SHOCK; TERTIARY HEALTH CARE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADOLESCENT; ANEMIA; CHILD; CHILD, PRESCHOOL; COINFECTION; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INDIA; INFANT; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MULTIPLE ORGAN FAILURE; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; SURVIVAL ANALYSIS; TERTIARY CARE CENTERS; THROMBOCYTOPENIA;

EID: 84871427293     PISSN: 20469047     EISSN: 20469055     Source Type: Journal    
DOI: 10.1179/2046905512Y.0000000012     Document Type: Review

References (23)

1. World Health Organisation. World Malaria Report 2009. Geneva, Switzerland: WHO, 2009.
2. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005;434:214-17.
3. World Health Organisation. World Malaria Report 2010. Geneva, Switzerland: WHO, 2010.
4. Kumar A, Valecha N, Jain T, Dash AP. Burden of malaria in India: retrospective and prospective view. Am J Trop Med Hyg. 2007;77 (suppl 6):69-78.
5. Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, et al. Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India. Am J Trop Med Hyg. 2009;80:194-8.
6. Kochar DK, Tanwar GS, Khatri PC, Kochar SK, Sengar GS, Gupta A, et al. Clinical features of children hospitalized with malaria-a study from Bikaner, northwest India. Am J Trop Med Hyg. 2010;83:981-9.
7. Genton B, D'Acremont V, Rare L, Baea K, Reeder JC, Alpers MP, et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 2008;5:e127.
8. Tjitra E, Anstey NM, Sugiarto P, Warikar N, Kenangalem E, Karyana M, et al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008;5:e128.
9. Rodriguez-Morales AJ, Benítez JA, Arria M. Malaria mortality in Venezuela: focus on deaths due to Plasmodium vivax in children. J Trop Pediatr. 2008;54:94-101.
10. Yadav D, Chandra J, Aneja S, Kumar V, Kumar P, Dutta AK. Changing profile of severe malaria in North Indian children. Indian J Pediatr. 2011 [Epub ahead of print].
11. World Health Organization: Guidelines for the Treatment of Malaria, 2nd edn. Geneva, Switzerland: WHO, 2010.
12. Tripathy R, Parida S, Das L, Mishra DB, Tripathy D, Das MC, et al. Clinical manifestations and predictors of severe malaria in Indian children. Pediatrics. 2007;120:e454-60.
13. Mohan A, Sharma SK, Bollineni S. Acute lung injury and acute respiratory distress syndrome in malaria. J Vector Borne Dis. 2008;45:179-93.
14. Gupta S, Gunter JT, Novak RJ, Regens JL. Patterns of Plasmodium vivax and Plasmodium falciparum malaria underscore importance of data collection from private health care facilities in India. Malar J. 2009;8:227.
15. Kochar DK, Das A, Kochar A, Middha S, Acharya J, Tanwar GS, et al. Thrombocytopenia in Plasmodium falciparum, Plasmodium vivax and mixed infection malaria: a study from Bikaner (Northwestern India). Platelets. 2010;21:623-7.
16. Anstey NM, Russell B, Yeo TW, Price RN. The pathophysiology of vivax malaria. Trends Parasitol. 2009;25:220-7.
17. Greenbaum DC, FitzGerald GA. Platelets, pyrexia, and plasmodia. N Engl J Med. 2009;361:526-8.
18. Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis. 2009;9:555-66.
19. Anstey NM, Jacups SP, Cain T, Pearson T, Ziesing PJ, Fisher DA, et al. Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer and increased pulmonary phagocytic activity. J Infect Dis. 2002;185:1326-34.
20. Anstey NM, Handojo T, Pain MCF, Kenangalem E, Tjitra E, Price RN, et al. Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and post treatment alveolar-capillary inflammation. J Infect Dis. 2007;195:589-96.
21. Rogerson SJ, Carter R. Severe vivax malaria: newly recognised or rediscovered. PLoS Med. 2008;5:e136.
22. Valecha N, Joshi H, Eapen A Ravinderan J, Kumar A, Prajapati SK, et al. Therapeutic efficacy of chloroquine in Plasmodium vivax from areas with different epidemiological patterns in India and their Pvdhfr gene mutation pattern. Trans R Soc Trop Med Hyg. 2006;100:831-7.
23. Singh N, Shukla MM, Shukla MK, Mehra RK, Sharma S, Bharti PK, et al. Field and laboratory comparative evaluation of rapid malaria diagnostic tests versus traditional and molecular techniques in India. Malaria J. 2010;9:191.